Wantai SARS-CoV-2 IgM ELISA

Manufactured by Beijing Wantai Biological Pharmacy Enterprise Co. Ltd., China - www.ystwt.cn 

Related Scientific Literature

• Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 pneumonia
• Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies
• COVID-19 Serological Tests: How Well Do They Actually Perform?
• An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment
• Antibody tests in detecting SARS-CoV-2 infection: A meta-analysis
• Diagnostic performance of serological assays in the detection of SARS-CoV-2: A review
• Review of Current Advances in Serologic Testing for COVID-19
• Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020
• Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid Tests
• Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset
• Comparison of sixteen serological SARS-CoV-2 immunoassays in sixteen clinical laboratories
• Herd immunity is not a realistic exit strategy during a COVID-19 outbreak

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements